CS
YTEN

Credit Suisse’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Credit Suisse’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-13
Closed -$24K – 4186
2018
Q1 		$24K Buy
+13
New +$22K ﹤0.01% 3924

Other funds holding YTEN

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Credit Suisse's YTEN Position: Q2 2018 in Review

Credit Suisse sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2018, closing a stake of 13 shares — an estimated $24K sold.

Credit Suisse first reported a position in YTEN in Q1 2018 and held it in 1 quarter. The position peaked at $24K in Q1 2018. 12 funds tracked by Wall St. Rank hold YTEN as of Q2 2018.

  • Credit Suisse reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Credit Suisse sold 13 Yield10 Bioscience, Inc. Common Stock shares in Q2 2018, an estimated $24K.
  • Credit Suisse first reported a position in Yield10 Bioscience, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
  • Credit Suisse's Yield10 Bioscience, Inc. Common Stock position peaked at $24K in Q1 2018.
  • 12 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2018.

Based on Credit Suisse's 13F filing for Q2 2018, filed 14 Aug 2018.